Obituary Michel Roy

Dear all,

It is with deep emotion that we learn of the death of our long-time friend Michel Roy.

Michel was an exceptional man for his empathy and his bravery. He was affectionate, endearing and tender, and had that elegance of a great man. I had forged a relationship of friendship with him and Denise, whom I think very strongly today. He has given much to our scientific community in cervical and vulvar pathology and his teaching of great quality was appreciated by all.

We are sad that he will no longer be with us. Our thoughts go to Denise, a wonderful woman with whom he formed a united and solid couple. We also think of his children and grandchildren whom he loved.

Michel will be missed, we will not forget him.

Sincere condolences,

Joseph Monsonego,
EUROGIN Chair

I attended EUROGIN 2021

Watch the VOD and claim your certificate of attendance & CME credits

MORE INFORMATION

Workshop Francophone

ACCÉDER À LA VOD

EUROGIN 2021 VOD ACCESS

This year, EUROGIN 2021 took place virtually and we are delighted to announce that it was a huge success.

Although you were not present for this year’s conference, our new VOD Access will allow you to watch and benefit from the extensive EUROGIN 2021 scientific program consisting of over 40 presentations and workshops.

All presentations and workshops are available now on-demand until 30^th September 2021.

Register for the VOD Access for just €275 to begin watching.

PURCHASE VOD ACCESS

Available until 30^th September

EUROGIN PRE-CONGRESS WEBINAR SERIES

HIGHLIGHTS ON HPV INFECTION & ASSOCIATED CANCER
FROM RESEARCH TO PRACTICE

MORE INFORMATION

REPLAY OUR PAST WEBINARs

On-demand Webinars

Host-cell DNA Methylation Markers for Anogenital Cancer

Daniëlle Heideman - Renske Steenbergen

Disruption of DNA methylation patterns is one of the hallmarks of cancer, including high-risk human papillomavirus (hrHPV)-driven anogenital cancers. Several hyper-methylated cellular genes have been found associated with carcinogenesis of the uterine cervix or other anogenital sites. This finding is now increasingly being used as morphology-independent biomarker for the management of hrHPV-positive women in cervical screening, or for risk stratification of patients diagnosed with premalignant anogenital disease (CIN, VIN, AIN). The webinar will highlight research on altered DNA methylation in hrHPV-induced carcinogenesis, and the potential clinical applications thereof.

▶ Replay

Updates in HPV-positive Head and Neck Cancers

Eleni Rettig

Overview of recent developments in epidemiology, management, and biomarkers of HPV-positive head and neck cancers.

▶ Replay

HPV Vaccine Immune Responses by Age and Gender

Joakim Dillner

Vaccination strategies used will greatly affect the progress towards elimination. I will discuss effectiveness and immunity depending on age groups and genders to be targeted.

▶ Replay

Cervical cancer prevention: HPV Vaccine Impact and Safety

Julia Brotherton

This webinar will provide a brief primer on the mountain of evidence now supporting both the safety and impact of HPV vaccines in population use, as an introduction to the latest data which will be presented at Eurogin 2021.

▶ Replay

Risk Adapted Triage for Cervical Screening

Jack Cuzick

There are no clear factors for deciding who to screen for cervix cancer, other than previous abnormalities and the results of an initial test. The initial test can be either cytology or HPV testing. As we are moving towards primary HPV testing the focus here will be on the risk of disease based on a primary HPV test, how this can be refined by doing different triage tests. These include HPV genotyping, cytology, methylation, and p16 in a liquid-based sample. Algorithms for how best to employ these (depending on what is routinely available) will be discussed.

▶ Replay

TESTIMONIALS

Testimonials

“Even in a non-conventional format, EUROGN 2021 was an excellent event, well organized and full of important topics and discussions.
Congratulations for making this possible in a very difficult year!”
Paolo Bonanni

“I thought EUROGIN was a great success. I learnt so much.
Of course, I miss the human interaction but well done for putting together such a comprehensive program”
Kate Cuschieri

“Your persistence during the difficult times has been admirable!”
Joakim Dillner

“Thank you very much for the successful online meeting”
Jacob Bornstein

“Congrats to you and the whole Eurogin team to organize such a fantastic virtual format of the congress.”
Magnus Von Knebel Doeberitz

WATCH ALL TESTIMONIALS

Sponsorship

For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]

Sponsors & Exhibitors List

SEE THE 2021 EXHIBITORS LIST

EXHIBITING OPPORTUNITIES

Ethical Med Tech

The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conferene vetting system on all assessment criteria:

Scientific Programme
Geographic Location
Conference Venue
Hospitality
Registration Packages
Communication

I attended EUROGIN 2021

Watch the VOD and claim your certificate of attendance & CME credits

Workshop Francophone

EUROGIN 2021 VOD ACCESS

All presentations and workshops are available now on-demand until 30^th September 2021.